Patient Education & FAQ

Tests for suspected multiple sclerosis: preparing for MRI, spinal-fluid testing, and specialist review

An MS assessment is designed to explain a neurological problem, not simply to complete a standard package of tests. A first episode of visual loss, an incidental MRI finding, and several years of unexplained walking difficulty call for different questions. Before arranging investigations in China, collect what has already been done and identify what remains uncertain. Repeating everything can add expense without resolving the diagnostic issue.

Key takeaways

These excerpts come from the original article. Read the full sections below for context.

  • Write down each possible episode separately, including its onset, duration, affected functions, and recovery. Approximate dates are acceptable if identified as estimates. Old admission records, sick-leave dates, or scan appointments can help reconstruct the sequence. Tell the clinician about fever, infection, heat exposure, other illnesses, and medicines taken around each event.
  • Depending on the clinical picture, laboratory tests may address nutritional, metabolic, infectious, autoimmune, or other causes. There is no routine blood test that independently confirms every case of MS. A targeted investigation can be more informative than a broad panel with results that are difficult to interpret. Ask what question each requested test is intended to answer. Chinese MS diagnosis and treatment guideline
  • When booking, explain whether the consultation concerns a first diagnosis, a disputed diagnosis, or preparation for treatment. MRI, eye testing, and specialist CSF assays may follow different schedules. Confirm how a final discussion can occur if all results are not available before departure. Do not assume that one admission guarantees completion of every investigation.

Quick answer

An MS assessment is designed to explain a neurological problem, not simply to complete a standard package of tests. A first episode of visual loss, an incidental MRI finding, and several years of unexplained walking difficulty call for different questions. Before arranging investigations in China, collect what has already been done and identify what remains uncertain. Repeating everything can add expense without resolving the diagnostic issue.

Full guide

An MS assessment is designed to explain a neurological problem, not simply to complete a standard package of tests. A first episode of visual loss, an incidental MRI finding, and several years of unexplained walking difficulty call for different questions. Before arranging investigations in China, collect what has already been done and identify what remains uncertain. Repeating everything can add expense without resolving the diagnostic issue.

Begin with a usable clinical history

Write down each possible episode separately, including its onset, duration, affected functions, and recovery. Approximate dates are acceptable if identified as estimates. Old admission records, sick-leave dates, or scan appointments can help reconstruct the sequence. Tell the clinician about fever, infection, heat exposure, other illnesses, and medicines taken around each event.

The neurological examination evaluates functions such as vision, eye movements, strength, sensation, coordination, and walking. Symptoms and examination findings do not always match neatly, and that may prompt further assessment. A mismatch does not establish that the symptoms are unimportant. Severe new visual loss, weakness, or inability to walk should receive timely clinical attention rather than wait for a routine investigation schedule. NICE MS diagnosis and management recommendations

Understand what MRI is being asked to show

Brain imaging is central to many assessments. Spinal-cord or optic-nerve imaging may be added according to the presentation and remaining uncertainty. The updated MRI consensus addresses appropriate acquisition and interpretation within the revised diagnostic framework. Lesion distribution and characteristics matter, so a report listing several white-matter abnormalities cannot be interpreted by counting them alone. 2024 MAGNIMS–CMSC–NAIMS MRI consensus

Bring complete, readable image files from previous examinations. “A few lesions” in an old report and “multiple lesions” in a newer one do not necessarily establish a true increase. Equipment, sequences, image quality, and reporting language may differ. The receiving team needs to decide whether an apparent change reflects disease evolution or a technical difference.

Tell the imaging service about possible pregnancy, kidney disease, previous contrast reactions, implants, and retained metal. The team should determine whether contrast is useful for the particular question and whether the proposed examination is safe. An uneventful scan in the past does not remove the need to review current safety information.

The 2024 McDonald revision, published in 2025, includes the optic nerve as a fifth typical anatomical location. Central-vein signs and paramagnetic-rim lesions can provide additional evidence in particular pathways. These are not universally available tests that every patient must purchase. Ask whether an additional sequence would materially change the conclusion, rather than assuming that a longer scan is necessarily better. Revised McDonald diagnostic criteria

Ask how a lumbar puncture could change the assessment

A lumbar puncture collects cerebrospinal fluid, or CSF. Findings can support evaluation of inflammation within the central nervous system or suggest another cause. Oligoclonal bands and kappa free light-chain measurements require interpretation with the relevant serum information, laboratory method, and clinical setting. Neither is an isolated “MS-positive” result that overrides contradictory evidence. CSF use in the revised diagnostic framework

The value of the procedure depends on the question still unresolved. Ask what evidence is missing, what a positive or negative result would mean, and whether a reasonable alternative pathway exists. The discussion should cover benefit and risk. It should not be reduced to either refusing because the procedure sounds frightening or requesting every available CSF test to obtain certainty more quickly.

Before the procedure, disclose blood-thinning medicines, bleeding problems, recent infection, and relevant spinal surgery. The clinical team decides whether medicine changes are needed; do not stop prescribed treatment independently. Headache and back discomfort can occur afterward. Obtain instructions about recovery and about seeking assessment for persistent severe headache, fever, or new neurological problems. NHS lumbar-puncture patient information

Results may arrive in stages, particularly when samples are sent elsewhere. Before discharge, identify who will review outstanding findings and how the final report will reach you. Completing the puncture does not mean the diagnostic work has finished. This is especially important if your return flight is scheduled before specialist laboratory results are expected.

Clarify the purpose of visual investigations

An ophthalmic assessment may include optical coherence tomography, or OCT, and visual evoked potentials, or VEPs. OCT measures relevant retinal structures; VEPs provide information about conduction along the visual pathway. Their contribution to the revised MS criteria depends on proper technique, quality control, and the absence of a better explanation for optic-nerve injury. Consensus on OCT and VEP use

Other retinal or optic-nerve diseases, the timing of an acute event, and technical factors can affect interpretation. A coloured flag on an OCT printout does not diagnose MS. If you have tests from several hospitals, preserve the dates and device information. The clinician may need to distinguish recent changes from older injury or measurement differences.

Describe recovery as well as the initial problem. Vision that feels normal today does not completely describe a previous episode, while persistent blur may have several explanations. Appropriate eye assessment helps the neurologist decide what evidence can legitimately contribute to the diagnosis.

Use blood tests to investigate plausible alternatives

Depending on the clinical picture, laboratory tests may address nutritional, metabolic, infectious, autoimmune, or other causes. There is no routine blood test that independently confirms every case of MS. A targeted investigation can be more informative than a broad panel with results that are difficult to interpret. Ask what question each requested test is intended to answer. Chinese MS diagnosis and treatment guideline

AQP4-IgG testing is relevant when neuromyelitis optica spectrum disorder is a plausible alternative, including certain patterns of optic neuritis or myelitis. The assay and sampling context should be recorded. Distinguishing NMOSD from MS matters because their long-term treatment pathways differ. It is not simply a change in terminology on the same prescription. NEMOS diagnostic and differential-diagnosis recommendations

MOG-IgG results also require a compatible clinical setting and careful interpretation. An isolated low-positive result cannot automatically reclassify nonspecific symptoms or incidental lesions as MOG antibody-associated disease. If a second opinion changes the proposed diagnosis, request an explanation of the specific evidence responsible and any further confirmation needed. International MOGAD diagnostic criteria

Separate diagnosis from treatment-safety screening

A patient may meet diagnostic requirements and still need additional blood tests before starting a DMT. Liver or kidney measurements, infection screening, and immune assessments may relate to a proposed medicine rather than uncertainty about MS itself. Ask which stage of care each test belongs to and how an abnormal result would affect timing or treatment selection.

The required evaluation should follow the current information for the actual medicine being considered. For example, the Chinese ocrelizumab label describes treatment-specific safety assessment and infusion precautions. It is not a universal checklist for every MS therapy. Copying another patient's laboratory requests can miss relevant tests while adding unnecessary ones. Chinese ocrelizumab prescribing information

Leave uncertainty with a plan attached

The outcome of a consultation may be confirmed MS, a different diagnosis, or a need for further observation. Revised criteria allow earlier diagnosis in selected situations, but they do not eliminate every uncertainty. Ask the clinician to state the leading explanation, the missing evidence, and what will trigger a new assessment.

Keep a record of new symptoms and attend the agreed review. Adding a missing, clinically relevant spinal scan is different from repeating a complete investigation package without a specific question. If another test is proposed, ask what decision could change because of its result. This keeps follow-up focused on useful information.

Coordinate investigations in China before committing to a short trip

When booking, explain whether the consultation concerns a first diagnosis, a disputed diagnosis, or preparation for treatment. MRI, eye testing, and specialist CSF assays may follow different schedules. Confirm how a final discussion can occur if all results are not available before departure. Do not assume that one admission guarantees completion of every investigation.

Organize records around clinical events, linking each episode to its examination, scans, and treatment. Preserve original wording, units, reference ranges, and test methods where supplied. A summary saying only “all tests normal” may omit information the receiving specialist needs to verify.

For costs, request a list of tests considered necessary now and those conditional on earlier findings. Ask whether contrast, external laboratory work, or additional specialty appointments are billed separately. Before leaving, obtain the current diagnostic conclusion, outstanding results, follow-up arrangements, and a contact route. The purpose of testing is to support a medical decision that can be acted on after the visit.

Related guides